机构：[1]Institute of Cerebrovascular Disease Research and Department of Neurology, Xuanwu Hospital, the First Clinical Medical College of Capital Medical University, Beijing, China内科系统神经内科神经科系统江苏省人民医院脑血管病研究室神经内科[2]Beijing Geriatric Medical Research Center and Beijing Key Laboratory of Translational Medicine for Cerebrovascular Diseases, Beijing, China[3]Beijing Institute for Brain Disorders, Beijing, China
第一作者机构：[1]Institute of Cerebrovascular Disease Research and Department of Neurology, Xuanwu Hospital, the First Clinical Medical College of Capital Medical University, Beijing, China[2]Beijing Geriatric Medical Research Center and Beijing Key Laboratory of Translational Medicine for Cerebrovascular Diseases, Beijing, China
推荐引用方式(GB/T 7714)：
R. Wang,H. Zhao,G. Li,et al.MiR-424 prevents astrogliosis after cerebral ischemia in middle-aged mice by enhancing repressive H3K27me3 via targeting NFIA/DNMT1 pathway[J].JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM.2019,39:461-461.
APA：
R. Wang,H. Zhao,G. Li,Z. Tao,S. Zhang...&Y. Luo.(2019).MiR-424 prevents astrogliosis after cerebral ischemia in middle-aged mice by enhancing repressive H3K27me3 via targeting NFIA/DNMT1 pathway.JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM,39,
MLA：
R. Wang,et al."MiR-424 prevents astrogliosis after cerebral ischemia in middle-aged mice by enhancing repressive H3K27me3 via targeting NFIA/DNMT1 pathway".JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM 39.(2019):461-461
医学